Coca-Cola Femsa S.A.B. De C.V Reaches New 52-Week High (KOF)

NEW YORK ( TheStreet) -- Coca-Cola Femsa S.A.B. de C.V (NYSE: KOF) hit a new 52-week high Thursday as it is currently trading at $119.96, above its previous 52-week high of $119.83 with 4,189 shares traded as of 9:34 a.m. ET. Average volume has been 120,900 shares over the past 30 days.

Coca-Cola Femsa S.A.B. de C.V has a market cap of $22.46 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 23.5% year to date as of the close of trading on Wednesday.

Coca Cola FEMSA, S.A.B. de C.V., a franchise bottler, produces, markets, and distributes Coca-Cola trademark beverages. The company has a P/E ratio of 29.4, below the average food & beverage industry P/E ratio of 55.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Coca-Cola Femsa S.A.B. de C.V as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Coca-Cola Femsa S.A.B. de C.V Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Sell These 5 Stocks Now Before They Turn Toxic

Sell These 5 Stocks Now Before They Turn Toxic

Today's Strong And Under The Radar Stock: Coca-Cola Femsa SAB De CV (KOF)

Today's Strong And Under The Radar Stock: Coca-Cola Femsa SAB De CV (KOF)

Strong And Under The Radar Today: Coca-Cola Femsa SAB De CV (KOF)

Strong And Under The Radar Today: Coca-Cola Femsa SAB De CV (KOF)

3 Stocks Pushing The Consumer Goods Sector Higher

3 Stocks Pushing The Consumer Goods Sector Higher

Warren Buffett and Bill Gates: Best Buds, Investment Frenemies or a Little Bit of Both?

Warren Buffett and Bill Gates: Best Buds, Investment Frenemies or a Little Bit of Both?